Breast Cancer Treatment: The TAILORx Clinical Trial

TAILORx clinical trial findings will help personalize breast cancer treatment decisions.Earlier this month, the long-awaited results of the TAILORx clinical trial were announced.

The findings from this study are important for early stage breast cancer patients with hormone receptor-positive breast cancer. The study results are expected to assist many patients in this group in determining whether chemotherapy should be part of their treatment.

The TAILORx findings are also interesting when viewed as part of a developing trend in treatment for early stage breast cancer away from a one-size-fits all approach toward more personalized care.

The findings were presented at the annual meeting of the American Society for Clinical Oncology (ASCO) and also published in the New England Journal of Medicine (NEJM). Continue reading

5 Cancer Research Stories Worth Following – Spring 2018

A look at several "need-to-know" cancer research stories reported in Spring 2018.What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Among the topics we cover this time are ways in which researchers are working to improve immunotherapy treatments so they can be effective for more people. Continue reading

5 Cancer Research Stories Worth Following – Winter 2018

A look at several "need-to-know" cancer research stories reported in Winter 2018.What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Among the topics we cover this time are a new targeted therapy for cancer that’s making its way into breast cancer treatment and the possible negative impact on treatment effectiveness of certain compounds commonly found in food.

Continue reading

5 Cancer Research Stories Worth Following – Fall 2017

A look at several "need-to-know" cancer research stories for Fall 2017.What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this fall.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Topics covered this time include approval of a new drug to treat advanced breast cancer and a study on post-traumatic stress disorder in cancer survivors.

Continue reading

5 Cancer Research Stories Worth Following – Summer 2017

A look at several of the most interesting cancer research stories for Summer 2017What’s the latest news in cancer research that stands out the most? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this summer.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Topics covered this time include the first approval of a cancer drug based on a biomarker rather than the where in the body the cancer started, as well as a first approval for an innovative therapy in which a patient’s immune system cells are genetically engineered to attack cancer.

Continue reading

A Role for Progesterone in Breast Cancer Treatment?

New research sheds light on the role of progesterone in hormone receptor-positive breast cancer.Back in August 2015, I wrote about an article in the journal Nature on some interesting new discoveries about the role of the hormone progesterone in hormone receptor-positive breast cancer.

The research suggested that adding progesterone to standard treatment with tamoxifen or an aromatase inhibitor could increase the effectiveness of treatment for this subtype of breast cancer, while possibly also lowering toxicity.

Cancer Research UK reports that these findings are now going to be investigated in three clinical trials that are set to begin.  Continue reading

5 Cancer Research Stories Worth Following – Spring 2017

Cancer research stories worth following this spring include a study on the benefits of immunotherapy for breast cancer patients.What’s the latest news in cancer research that we need to know about? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Topics covered this time include studies reported at the recent annual meeting of the American Association for Cancer Research on the use of PARP inhibitors to treat different types of cancer, as well as a study on the benefits of immunotherapy for triple negative breast cancer.

Continue reading

5 Cancer Research Stories Worth Following – Winter 2017

 

Cancer research stories worth following for Winter 2017 include a possible use of an existing drug in triple negative breast cancer to prevent metastasis.What’s the latest news in cancer research that we need to know about? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Topics covered this time include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer, and new imaging technology that could provide a noninvasive way to monitor ongoing treatment.

Continue reading

10 Things We Learned About Progress Against Cancer in 2016

A review of cancer research developments in 20162016 was not a year for big breakthroughs in cancer research and improving access to quality care. And yet, it was a year in which many of the issues that need to be addressed if we want to ever see those breakthroughs were front and center.

Those issues include the need for collaborative research and sustained research funding, finding ways to make immune system treatments safer and effective for more patients and addressing the problem of outrageously high drug prices.  Continue reading

5 Cancer Research Stories Worth Following – Fall 2016

Cancer research stories worth following for fall 2016 include a possible new addition to the treatment toolkit for advanced ovarian cancer.What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this fall.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Stories worth following this fall include two studies on financial toxicity and new developments in targeted cancer therapies for ovarian cancer and for metastatic breast cancer.  Continue reading